US Broker Ratings

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Waters with a 12% Downside

Investors eyeing the biotechnology sector often seek innovative companies with promising pipelines and strategic partnerships. Galapagos NV (GLPG), a Belgian biotech firm specializing in oncology and..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A Healthcare Innovator with 7.35% Potential Upside

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a pioneering medical technology company in the healthcare sector, has been making waves with its innovative products in the realm..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring an 82.97% Potential Upside in the Biotech Arena

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is garnering attention in the biotechnology sector with its focus on pioneering treatments for rare endocrine diseases and tumors. This clinical-stage..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: High Growth Potential Despite Challenges

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands at an intriguing juncture for investors, offering a compelling mix of high growth potential and notable risks. With a market..

CONMED Corporation (CNMD): Investor Outlook on Valuation and Growth Potential with a 24.71% Upside

CONMED Corporation (NASDAQ: CNMD), a prominent player in the healthcare sector, specifically within the medical devices industry, is gaining significant attention from investors due to its..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Biotechnology Innovator with Over 105% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is capturing investor attention with its innovative approach to addressing chronic diseases through novel oral small molecule..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Navigating Growth Amid Healthcare Challenges

Pediatrix Medical Group, Inc. (NYSE: MD), operating within the healthcare sector and specializing in medical care facilities, presents a compelling case for investors seeking exposure to..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 34.38% Potential Upside in the Healthcare Sector

AdaptHealth Corp. (NASDAQ: AHCO), a key player in the healthcare sector, specializes in the distribution of home medical equipment and services across the United States. With..

Schrodinger, Inc. (SDGR) Stock Analysis: A 59% Upside Potential in the Cutting-Edge Healthcare Sector

Schrodinger, Inc. (NASDAQ: SDGR) is making waves in the healthcare sector with its innovative approach to drug development and materials science. With a market capitalization of..

Apogee Therapeutics (APGE) Stock Analysis: Unveiling a 42% Potential Upside

Apogee Therapeutics, Inc. (NASDAQ: APGE) is catching the eye of investors with a compelling opportunity for growth in the biotechnology sector. As a clinical-stage company, Apogee..

Azenta, Inc. (AZTA) Stock Analysis: Is There a 2.45% Upside for Investors?

Azenta, Inc. (NASDAQ: AZTA) navigates the dynamic landscape of the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.68..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a Potential 51% Upside with Strategic Partnerships

Innoviva, Inc. (NASDAQ: INVA), a key player in the biotechnology sector, has caught the attention of investors with its recent price activity and strategic collaborations. As..

Perrigo Company plc (PRGO) Stock Analysis: Unpacking a Potential 69% Upside in the Healthcare Sector

Perrigo Company plc (PRGO), a notable player in the healthcare sector, stands at an intriguing juncture for investors. With its headquarters in Dublin, Ireland, Perrigo operates..

10x Genomics, Inc. (TXG) Stock Analysis: A Healthcare Innovator with Mixed Outlooks Amidst Analyst Ratings

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, is making waves with its innovative life science technology products. Known for its cutting-edge..

IDEAYA Biosciences, Inc. (IDYA): Analyst Ratings Suggest a 42.69% Potential Upside for This Biotech Innovator

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) has captured the attention of investors in the biotechnology sector with its promising pipeline of targeted therapeutics and strategic partnerships. As..

MannKind Corporation (MNKD) Investor Outlook: Exploring an 83% Potential Upside and Promising Biopharmaceutical Developments

MannKind Corporation (NASDAQ: MNKD) has been capturing the attention of investors with its robust potential for growth in the biopharmaceutical sector. With a market capitalization of..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a 90% Potential Upside in the Healthcare Sector

Dynavax Technologies Corporation (NASDAQ: DVAX) presents a compelling opportunity for investors intrigued by the healthcare sector’s potential. With a market capitalization of $1.34 billion, this Emeryville,..

Arcellx, Inc. (ACLX) Stock Analysis: A Biotech Gem with 50% Upside Potential

Arcellx, Inc. (NASDAQ: ACLX), a pioneering player in the biotechnology sector, is drawing significant attention from investors, thanks to its promising pipeline of immunotherapy candidates and..

Celldex Therapeutics, Inc. (CLDX) Investor Outlook: Exploring a Potential 101.91% Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a biopharmaceutical company rooted in the biotechnology sector, is creating a buzz with its innovative therapeutic antibody developments aimed at treating..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Envisioning a 256.99% Upside in Biotech Innovation

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents a compelling opportunity for individual investors navigating the dynamic biopharmaceutical sector. With a market capitalization of $793.75 million, this San..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds